Turnstone Biologics Corp.
TSBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70,837 | -$55,200 | -$30,834 | $33,269 |
| Dep. & Amort. | $1,835 | $2,798 | $3,901 | $1,390 |
| Deferred Tax | $0 | -$5,135 | $7,516 | $1,691 |
| Stock-Based Comp. | $3,676 | $4,216 | $6,419 | $2,612 |
| Change in WC | $47 | -$17,922 | -$57,966 | -$85,755 |
| Other Non-Cash | -$2,159 | $5,091 | -$98 | $1,164 |
| Operating Cash Flow | -$67,438 | -$66,152 | -$71,062 | -$45,629 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$229 | -$1,249 | -$5,170 | -$3,406 |
| Net Acquisitions | $25 | $452 | $0 | $0 |
| Inv. Purchases | -$6,741 | -$109,796 | -$59,512 | -$41,387 |
| Inv. Sales/Matur. | $85,500 | $82,500 | $49,750 | $41,445 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $78,555 | -$28,093 | -$14,932 | -$3,348 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $44 | $77,839 | $157 | $79,954 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$33 | -$793 | -$2,813 | $339 |
| Financing Cash Flow | $11 | $77,046 | -$2,656 | $79,954 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,128 | -$17,199 | -$88,650 | $30,977 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,914 | $35,113 | $123,763 | $92,786 |
| End Cash | $29,042 | $17,914 | $35,113 | $123,763 |
| Free Cash Flow | -$67,667 | -$67,401 | -$76,232 | -$49,035 |